EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report

Toru Horinouchi iD, Mayusa Mito, Toshiyuki Ishikawa, Yuichi Nakamura, Shuhei Ishikawa, Naoki Hashimoto

Psychiatry and Clinical Neurosciences Reports · 2026-06 · 5 (2)

DOI: 10.1002/pcn5.70330 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 07.04.2026. Verfasst von Toru Horinouchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurology Hokkaido University Hospital Sapporo Hokkaido Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment‐resistant schizophrenia (TRS) poses a substantial clinical challenge for which clozapine (CLOZ) is the only effective treatment. However, clinicians may hesitate to prescribe CLOZ for TRS patients with epilepsy due to its presence because CLOZ is contraindicated in patients with uncontrolled epilepsy in some countries including Japan. Case Presentation A 36‐year‐old male with TRS and focal epilepsy underwent CLOZ therapy. CLOZ was initiated at 6.25 mg and gradually titrated to 250 mg over 3 months, achieving a plasma concentration of 449 ng/mL. Psychotic symptoms improved without worsening of seizure frequency or severity. Mild side effects such as drowsiness and drooling were manageable. Long‐term video electroencephalography monitoring detected spike‐and‐wave activity centered in the frontal region, but did not detect any overt epileptic seizures.

Conclusion

We report a case of TRS with comorbid epilepsy in which CLOZ therapy was both effective and safe.

Schlagwörter

Stichwörter der Autor:innen

antipsychoticsclozapineepilepsyseizuretreatment‐resistant schizophrenia

Autor:innen und Institutionen

  • Department of Psychiatry and Neurology Hokkaido University Hospital Sapporo Hokkaido Japan.
  • Epilepsy Center Hokkaido University Hospital Sapporo Hokkaido Japan.
  • Department of Psychiatry Tokyo Metropolitan Matsuzawa Hospital Setagaya-ku Tokyo Japan.

ORCID-Profile: Toru Horinouchi

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Horinouchi, T., Mito, M., Ishikawa, T., Nakamura, Y., Ishikawa, S., & Hashimoto, N. (2026). Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report. Psychiatry and Clinical Neurosciences Reports, 5(2). https://doi.org/10.1002/pcn5.70330

Vancouver

Horinouchi T, Mito M, Ishikawa T, Nakamura Y, Ishikawa S, Hashimoto N. Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report. Psychiatry and Clinical Neurosciences Reports. 2026;5(2). doi:10.1002/pcn5.70330

BibTeX
@article{Horinouchi2026,
  author = {Horinouchi, Toru and Mito, Mayusa and Ishikawa, Toshiyuki and Nakamura, Yuichi and Ishikawa, Shuhei and Hashimoto, Naoki},
  title = {Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report},
  journal = {Psychiatry and Clinical Neurosciences Reports},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.1002/pcn5.70330}
}
Kostenlos starten →